Searched for
NOMURA ON HOSPITALITY STOCKS
India's hospitality sector enters a 'golden cycle' as luxury demand outpaces supply: NomuraIndia's hotel industry is entering a strong growth phase. Average daily rates are rising, and investment returns are attractive. Demand is ...- Nomura initiates coverage on ITC Hotels, IHCL with Buy rating. Check target price, upside potentialNomura has initiated coverage on ITC Hotels and Indian Hotels Company with a Buy rating, citing strong demand trends and asset-light expans...
- DLF shares up 3% after Rs 20,000 crore investment plan. Here's what brokerages sayShares of DLF Ltd increased by 2.6% to Rs 715 following the company's announcement to invest Rs 20,000 crore in commercial expansion. Despi...
- 2 reasons why Nomura not ruling out Nifty fall towards 21,800 by DecemberThe brokerage projects Nifty in the 21,800-25,700 range, based on 17.0-20.0X December 2026F earnings. In a best-case scenario, Nifty could ...
- Hot stocks: Brokerage view on Reliance, Apollo Hospitals, Zydus Life and L&TSeveral brokerage firms provided ratings on notable companies. CLSA rated Reliance as Outperform with a Rs 3,300 target. Nomura downgraded ...
- Samvardhana Motherson's stock target rise up to Rs 180. Should you buy, sell or hold?Brokerages raised target prices for auto components maker Samvardhana Motherson International to Rs 180 as it reported a two-fold jump in n...
- Jupiter Life Line Hospitals shares list at 32% premium over IPO priceShares of Jupiter Life Line Hospitals debuted at a premium of 32.4% on NSE and 30.6% premium on BSE. Jupiter Life Line Hospitals was subscr...
- Hot Stocks: Brokerages view on steel stocks, Apollo Hospitals, PB Fintech, Biocon and othersJP Morgan on Tata Steel and SAIL said, "Investor sentiment remains bearish on metals, lacking a meaningful demand recovery in China. Either...
- Expensive valuations? Half of Nifty50 stocks trade at discount to historical averagesIn the case of ONGC, the average target based on 23 analyst recommendations stands at Rs 173.71, suggesting a 33 per cent potential upside....
- Q1 profit down 69%, but D-St analysts see 20% upside in this Rakesh Jhunjhunwala betRakesh Jhunjhunwala owned 31,950,000 shares or 4.23 per cent stake in the company as of June 30. He had been staying status quo on his Fort...
- Street mavens cheer Apollo Hospitals’ plan‘Digital health space foray likely to broaden reach, boost growth’
- Analyst Calls: Cipla, Mindtree, Sun TVElara Capital has a buy rating on Cipla with a target price of Rs 685.
- Neutral on Dr Lal Pathlabs, target price Rs 1,471: NomuraThe company has started testing in Delhi but it is unlikely to have a positive impact on FY21 earnings, said Nomura.
- Investors Bet Big on Open Offer for FortisGopikishan Damani of D-Mart, BlackRock, York Strategic Fund look to make quick bucks via exit.
- Nomura downgrades Fortis Healthcare to neutralThe brokerage said Fortis’ revenue growth has remained muted over the past two years.
- Brokers’ Call: Apollo Hospital, Tech Mahindra and United SpiritNomura has downgraded Apollo Hospital to ‘Neutral’ on the back of muted earnings growth and the recent strong rally in the stock.
- JP Morgan downgrades Apollo Hospitals to 'neutral' on muted growth outlookIn a separate note, Nomura has also downgraded Apollo Hospitals to ‘neutral’ and has slashed its target price to Rs 933 from Rs 950 earlier.
- Brokers' call on Hindustan Unilever, Apollo HospitalsMacquarie has upgraded Hindustan Unilever to ‘Outperform’ as it expects annual earnings to grow 19% CAGR in the next five years.
- Brokerages remain 'Neutral' on Fortis HealthcareFortis announcement to acquire Fortis Int. has come as a surprise and puzzled shareholders by the apparent change in the strategy
- Apollo Hospitals launches QIP exercise to raise Rs 330 crApollo Hospitals today said it has initiated a share sale to qualified institutional buyers to raise up to Rs 330 crore, which the firm pla...
Load More
